| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $893.00K | $76.00K | $0.00 | $0.00 | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $165.90M | $183.75M | $151.52M | $153.01M | $55.11M |
| R&D | $114.12M | $127.67M | $106.71M | $82.07M | $46.26M |
| SG&A | $51.78M | $56.08M | $44.81M | $70.94M | $8.86M |
| Operating Income | -$165.01M | -$183.68M | -$151.52M | -$153.01M | -$55.11M |
| Interest Expense | $4.00K | $9.00K | $12.00K | $215.00K | $0.00 |
| Tax Expense | $414.00K | -$598.00K | $6.00M | $896.00K | $38.00K |
| Net Income | -$68.99M | -$61.19M | -$35.47M | -$148.13M | -$55.15M |
| EPS (basic) | – | – | – | -0.2300 | – |
| EPS (diluted) | – | – | – | -0.2300 | – |
| Shares (diluted) | – | – | – | $61.54M | – |